Conjunctivitis  >>  mapracorat (BOL-303242-X)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mapracorat (BOL-303242-X) / Bayer
NCT01289431: Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Completed
2
236
US
Mapracorat, Vehicle
Bausch & Lomb Incorporated
Conjunctivitis, Allergic
04/11
04/11

Download Options